All of the lawsuits allege the hip components caused plaintiffs to suffer a number of serious complications, including metallosis, necrosis and osteolysis. As of July 9th, at least 161 Stryker hip lawsuits were pending in the New Jersey litigation. An additional 159 Stryker hip lawsuits have also been transferred to a multidistrict litigation now underway in U.S. District Court, District of Minnesota. (In re: Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation, MDL No. 2441) Since the Stryker recall was announced, the company has warned that recipients of Rejuvenate and ABG II stems may be at risk for adverse local tissue reactions characterized by pain and swelling around the hip joint. Stryker is now advising all patients with the affected implants to undergo medical screening to ensure their hips are functioning properly, regardless of their symptoms.*